Estimation of serum Alpha feto-protein (AFP), interlukin-6 and Des-?-carboxyprothrombin (DCP) in case of hepatocellular carcinoma

Authors

  • Syed Shahzadul Haque Biochemist, Dept. of Clinical Biochemistry, Indira Gandhi Institute of Medical Sciences, Patna-14
  • Rekha Kumari Assistant professor, Dept. of Clinical Biochemistry, Indira Gandhi Institute of Medical Sciences, Patna-14
  • Ali Muzaffar Senior Resident, Dept. of Pathology, Indira Gandhi Institute of Medical Sciences, Patna-14
  • Uday Kumar Professor & Head, Dept. of Clinical Biochemistry, Indira Gandhi Institute of Medical Sciences, Patna-14
  • Anand Sharan Professor, Dept. of Clinical Biochemistry, Indira Gandhi Institute of Medical Sciences, Patna-14
  • Bandana Kumari Senior Resident, Dept. of Clinical Biochemistry, Indira Gandhi Institute of Medical Sciences, Patna-14

DOI:

https://doi.org/10.3329/bjms.v15i2.19602

Keywords:

AFP, DCP, IL-6, HCC

Abstract

Background: Hepatocellular carcinoma (HCC) is one the most common primary malignancy of the liver and represents the third leading cause of cancer-related deaths worldwide. Incidence rates are highest in East Asia and Sub-Saharan Africa. A number of evidence suggests a possible role of interleukin-6 (IL-6), ?-Fetoprotein (AFP) and Des-?-carboxyprothrombin (DCP) in the pathogenesis of hepatocellular carcinoma (HCC). The high DCP may be related to increase tumour behaviour, such as the presence of vascular invasion and intrahepatic metastasis of HCC cells.

Patients and methods: We studied IL-6, AFP and DCP in patients with HCC or in healthy controls. AFP was measured by chemiluminescent immunoassay; Serum IL-6 and DCP were measured by enzyme linked immunosorbent assay in 30 patients with primary hepatocellular carcinoma and 30 normal subjects.

Results: IL-6, AFP and DCP were found high in the serum of patients initially diagnosed with HCC (18±9.8), (315.99±594.62) and (26.15±5.01) respectively compared with healthy subjects (4.29±2.10), (3.13±1.27) and (4.25±1.22). A significant positive correlation was found between mean levels of IL- 6 & AFP in HCC (P < 0.05), Combination of IL-6, AFP and DCP improved the sensitivity in diagnosing HCC or predicting future HCC development.

Conclusions: IL-6, DCP along with AFP could be considered a promising tumor marker for HCC. DCP is a well recognized tumor marker for the screening and diagnosis of HCC. In particular, the diagnostic value of the test is significantly increased when combined with AFP.

Bangladesh Journal of Medical Science Vol.15(2) 2016 p.230-233

Downloads

Download data is not yet available.
Abstract
124
PDF
78

Downloads

Published

2016-08-10

How to Cite

Haque, S. S., Kumari, R., Muzaffar, A., Kumar, U., Sharan, A., & Kumari, B. (2016). Estimation of serum Alpha feto-protein (AFP), interlukin-6 and Des-?-carboxyprothrombin (DCP) in case of hepatocellular carcinoma. Bangladesh Journal of Medical Science, 15(2), 230–233. https://doi.org/10.3329/bjms.v15i2.19602

Issue

Vol. 15 No. 2 (2016)

Section

Original Articles

License

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.